A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...
Bacteriophages (phages) are viruses that kill bacteria. Phage therapy used as an experimental therapy in 51 cystic fibrosis patients with multi-drug resistant infections showed that most had a ...
A computational study shows for the first time how different parts of the human airway experience levels of pressure and ...
Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...
This editorial by Lucas Grundmeier represents the views of the Register's editorial board. The new report “Miracle of Breath” from the Register’s Iowa columnist, Courtney Crowder, spans decades to ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...
The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...
Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.
Insmed (INSM) stock is in focus as the company halts studies for lung disorder therapy brensocatib in hidradenitis ...
Gas prices have soared roughly 80% year to date. When transportation costs rise, so do the prices of most products. Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results